NO894707L - Fremgangsmaate for fremstilling av benzoksazinderivater. - Google Patents

Fremgangsmaate for fremstilling av benzoksazinderivater.

Info

Publication number
NO894707L
NO894707L NO89894707A NO894707A NO894707L NO 894707 L NO894707 L NO 894707L NO 89894707 A NO89894707 A NO 89894707A NO 894707 A NO894707 A NO 894707A NO 894707 L NO894707 L NO 894707L
Authority
NO
Norway
Prior art keywords
benzoksazine
derivatives
procedure
preparation
benzoksazine derivatives
Prior art date
Application number
NO89894707A
Other languages
English (en)
Norwegian (no)
Other versions
NO894707D0 (no
Inventor
Manfred Baumgarth
Rolf Gericke
Rolf Bergmann
Jacques De Peyer
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO894707D0 publication Critical patent/NO894707D0/no
Publication of NO894707L publication Critical patent/NO894707L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO89894707A 1988-11-26 1989-11-24 Fremgangsmaate for fremstilling av benzoksazinderivater. NO894707L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3840011A DE3840011A1 (de) 1988-11-26 1988-11-26 Benzoxazinderivate

Publications (2)

Publication Number Publication Date
NO894707D0 NO894707D0 (no) 1989-11-24
NO894707L true NO894707L (no) 1990-05-28

Family

ID=6367979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894707A NO894707L (no) 1988-11-26 1989-11-24 Fremgangsmaate for fremstilling av benzoksazinderivater.

Country Status (19)

Country Link
US (1) US5036068A (fr)
EP (1) EP0371312B1 (fr)
JP (1) JPH02193995A (fr)
KR (1) KR900007835A (fr)
AR (1) AR245449A1 (fr)
AT (1) ATE108789T1 (fr)
AU (1) AU625697B2 (fr)
CA (1) CA2003772A1 (fr)
DE (2) DE3840011A1 (fr)
DK (1) DK594689A (fr)
ES (1) ES2057067T3 (fr)
FI (1) FI895624A0 (fr)
HU (1) HUT56097A (fr)
IE (1) IE63766B1 (fr)
IL (1) IL92419A0 (fr)
NO (1) NO894707L (fr)
NZ (1) NZ231518A (fr)
PT (1) PT92397B (fr)
ZA (1) ZA899005B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303172A3 (fr) * 1987-08-14 1991-05-15 F. Hoffmann-La Roche Ag Oxyimino-céphalosporines
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1,3-苯并嗪衍生物、其生产方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54118120A (en) * 1978-03-07 1979-09-13 Riyouma Shisutemuzu Kk Method of processing clerk
JPS5643281A (en) * 1979-09-14 1981-04-21 Sankyo Co Ltd 1,3-benzoxazine derivative and its preparation
JPS57130979A (en) * 1981-02-09 1982-08-13 Sankyo Co Ltd 4-amino-1,3-benzoxazine derivative and its preparation
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
JPS63284547A (ja) * 1987-05-15 1988-11-21 Konica Corp 有機着色物質の光褪色防止方法

Also Published As

Publication number Publication date
DE3840011A1 (de) 1990-05-31
EP0371312B1 (fr) 1994-07-20
ES2057067T3 (es) 1994-10-16
AU4546589A (en) 1990-05-31
PT92397A (pt) 1990-05-31
IE63766B1 (en) 1995-06-14
DE58908070D1 (de) 1994-08-25
PT92397B (pt) 1995-08-09
HUT56097A (en) 1991-07-29
DK594689A (da) 1990-05-27
JPH02193995A (ja) 1990-07-31
HU896172D0 (en) 1990-02-28
ATE108789T1 (de) 1994-08-15
IL92419A0 (en) 1990-07-26
EP0371312A1 (fr) 1990-06-06
ZA899005B (en) 1990-08-29
KR900007835A (ko) 1990-06-02
NO894707D0 (no) 1989-11-24
FI895624A0 (fi) 1989-11-24
CA2003772A1 (fr) 1990-05-26
AR245449A1 (es) 1994-01-31
NZ231518A (en) 1991-07-26
US5036068A (en) 1991-07-30
AU625697B2 (en) 1992-07-16
IE893761L (en) 1990-05-26
DK594689D0 (da) 1989-11-24

Similar Documents

Publication Publication Date Title
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649L (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO905377D0 (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO892813D0 (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.
NO905047D0 (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO884100D0 (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO903254D0 (no) Fremgangsmaate for fremstilling av kinuklidin-derivater.
NO904362D0 (no) Fremgangsmaate for fremstilling av kromanderivater.